A PhaseII Study of Dose Schedule of TS-1 for Metastatic/Advanced Breast Cancer
- Conditions
- Metastatic/Advanced Breast Cancer
- Registration Number
- JPRN-UMIN000008879
- Lead Sponsor
- Wakayama Medical University, Department of Thoracic and Cardiovascular Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Not provided
1)Active double cancer. 2)Watery diarrhea. 3)Require administration of flucytosine, phenytoin, and warfarin. 4)The metastases to brain which require measures for the brain hypertension and urgent brain irradiation. 5)Extensive liver metastases, or lymphatic vessel-related metastases to lung with dyspnea. 6)A lesion targeted for an evaluation is only one, and there is an enforcement history of the radiotherapy to the part. 7)Pleural effusion, ascitic fluid, pericardial effusion to need urgent treatment. 8)Severe infections being suspected. 9)Interstitial pneumonia or pulmonary fibrosis. 10)HBs antigen is positive. 11)The diabetes patients with difficult control or during treatment with insulin. 12)Serious mental disorder. 13)Pregnant woman, a nursing mother or has a hope for the pregnancy. 14)The patients who are inappropriate to the study which judged by doctors.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression free survival (PFS)
- Secondary Outcome Measures
Name Time Method